The main reasons for performing the follow-up biopsy were clinical follow-up of steatosis diagnosed at the first biopsy (n = 28), persistent high levels of ALT/AST (n = 15), while other causes included suspected cirrhosis on ultrasound, staging of fibrosis, or ruling out other suspected diseases (n = 17). Here, GPT is linked to fibrosis.